Literature DB >> 23963686

Integration of single-layer skin hollow fibers and scaffolds develops a three-dimensional hybrid bioreactor for bioartificial livers.

Shichang Zhang1, Li Chen, Tao Liu, Zhengguo Wang, Yingjie Wang.   

Abstract

Bioartificial liver support systems are expected to be an effective therapy as a "bridge" for liver transplantation or reversible acute liver disease. A major roadblock in the application of bioartificial livers is the need for a bioreactor that fully meets the requirements of hepatocyte culture, mass transfer and immunobarriers. In this study, we developed a three-dimensional hybrid bioreactor (3DHB) on a base of single-layer skin polyethersulfone hollow fibers by integrating with polyurethane scaffolds. The mass transfer of bilirubin and albumin from the intracapillary space to the extracapillary space of the hollow fibers was not significantly different between 3DHBs and hollow fiber bioreactors (HFBs). Cell viability staining showed that high-density hepatocytes were uniformly found in different regions of the 3DHB after 7 days of culture. Liver-specific functions of human mature hepatocytes cultured in the 3DHB, such as albumin secretion, urea production, ammonia removal rate and cytochrome P450 activity, were maintained stably and were significantly higher compared with the HFB. These results indicated that the 3DHB has good mass transfer and improves cell distribution and liver-specific functions. Meanwhile, the ammonia and unconjugated bilirubin concentrations in plasma from patients with liver failure were significantly decreased during 6 h of circulation by hepatocytes cultured in the 3DHB. Most hepatocytes in the 3DHB were viable after 6 h exposure to the patient plasma. We further demonstrated that bioartificial liver systems with 3DHB can remove toxins from and endure the deleterious effects of the patient plasma. Therefore, the 3DHB has the potential to accomplish different actions for the clinical application of bioartificial livers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963686     DOI: 10.1007/s10856-013-5033-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  44 in total

1.  Optimization of hepatocyte spheroid formation for hepatic tissue engineering on three-dimensional biodegradable polymer within a flow bioreactor prior to implantation.

Authors:  E Török ; J M Pollok; P X Ma; P M Kaufmann; M Dandri; J Petersen; M R Burda; D Kluth; F Perner; X Rogiers
Journal:  Cells Tissues Organs       Date:  2001       Impact factor: 2.481

2.  Three-dimensional perfusion cultures of mouse and pig fetal liver cells in a packed-bed reactor: effect of medium flow rate on cell numbers and hepatic functions.

Authors:  Hirotoshi Miyoshi; Tomo Ehashi; Hideki Kawai; Norio Ohshima; Satoshi Suzuki
Journal:  J Biotechnol       Date:  2010-06-09       Impact factor: 3.307

3.  Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.

Authors:  Karim Si-Tayeb; Fallon K Noto; Masato Nagaoka; Jixuan Li; Michele A Battle; Christine Duris; Paula E North; Stephen Dalton; Stephen A Duncan
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

4.  Biocompatibility of modified polyethersulfone membranes by blending an amphiphilic triblock co-polymer of poly(vinyl pyrrolidone)-b-poly(methyl methacrylate)-b-poly(vinyl pyrrolidone).

Authors:  Fen Ran; Shengqiang Nie; Weifeng Zhao; Jie Li; Baihai Su; Shudong Sun; Changsheng Zhao
Journal:  Acta Biomater       Date:  2011-05-27       Impact factor: 8.947

5.  Rotating microgravity-bioreactor cultivation enhances the hepatic differentiation of mouse embryonic stem cells on biodegradable polymer scaffolds.

Authors:  Yingjie Wang; Yunping Zhang; Shichang Zhang; Guangyong Peng; Tao Liu; Yangxin Li; Dedong Xiang; Michael J Wassler; Harnath S Shelat; Yongjian Geng
Journal:  Tissue Eng Part A       Date:  2012-09-24       Impact factor: 3.845

6.  An organic-inorganic hybrid scaffold for the culture of HepG2 cells in a bioreactor.

Authors:  Ken Kataoka; Yoshitaka Nagao; Takamasa Nukui; Ichiro Akiyama; Kanji Tsuru; Satoshi Hayakawa; Akiyoshi Osaka; Nam-ho Huh
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

7.  The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model.

Authors:  Shin Enosawa; Tomoyuki Miyashita; Tomohiro Saito; Takeshi Omasa; Toshiharu Matsumura
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

Review 8.  A bioartificial liver--state of the art.

Authors:  Alastair J Strain; James M Neuberger
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

9.  Human hepatocyte functions in a crossed hollow fiber membrane bioreactor.

Authors:  Loredana De Bartolo; Simona Salerno; Efrem Curcio; Antonella Piscioneri; Maria Rende; Sabrina Morelli; Franco Tasselli; Augustinus Bader; Enrico Drioli
Journal:  Biomaterials       Date:  2009-01-31       Impact factor: 12.479

10.  Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model.

Authors:  Zhong Chen; Yitao Ding; Qingxiang Xu; Decai Yu
Journal:  Artif Organs       Date:  2003-07       Impact factor: 3.094

View more
  1 in total

1.  3D Culture System for Liver Tissue Mimicking Hepatic Plates for Improvement of Human Hepatocyte (C3A) Function and Polarity.

Authors:  Zhidong Jia; Yuan Cheng; Xinan Jiang; Chengyan Zhang; Gaoshang Wang; Jiecheng Xu; Yang Li; Qing Peng; Yi Gao
Journal:  Biomed Res Int       Date:  2020-03-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.